This study investigates sex differences in Alzheimer's disease-related pathology among adults with Down syndrome using plasma biomarkers, structural MRI, and cognitive assessments. Findings provide insight into sex-specific neurobiological differences across the Down syndrome Alzheimer's disease continuum and may inform future biomarker development and precision medicine approaches.